ABOUT THIS STUDY
Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study:
1. Patients diagnosed as relapsed or refractory B-cell precursor lymphoblastic leukemia (ALL).
2. Evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study.
Patients meeting any of the following criteria will not be included in the study:
1. Any patients who does not agree that Pfizer and companies working with Pfizer use
2. Patients to whom BESPONSA® is contraindicated as per the local labeling.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in